Benzinga | Nov 9, 2020 06:53AM EST

Zynerba Pharmaceuticals Q3 EPS $(0.31) Down From $(0.08) YoY

Zynerba Pharmaceuticals (NASDAQ:ZYNE) reported quarterly losses of $(0.31) per share. This is a 287.5 percent decrease over losses of $(0.08) per share from the same period last year.